UBAM - Swiss Equity AD CHFRegister to Unlock Ratings |
Performance History | 31/07/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 13.7 | 23.9 | -20.2 | 9.7 | 8.1 | |
+/-Cat | 3.3 | 3.9 | -11.5 | -1.3 | 2.0 | |
+/-B’mrk | - | 1.6 | -13.0 | 1.0 | 1.6 | |
Category: Switzerland Equity | ||||||
Category Benchmark: Morningstar Switzerland TME... |
Key Stats | ||
NAV 13/08/2024 | CHF 413.59 | |
Day Change | 0.45% | |
Morningstar Category™ | Switzerland Equity | |
ISIN | LU0367305280 | |
Fund Size (Mil) 13/08/2024 | CHF 1734.38 | |
Share Class Size (Mil) 13/08/2024 | CHF 42.19 | |
Max Initial Charge | - | |
Ongoing Charge 19/02/2024 | 1.44% |
Investment Objective: UBAM - Swiss Equity AD CHF |
This sub-fund invests its net assets primarily in equities and other similar transferable securities, in addition to, on an ancillary basis, warrants on transferable securities, convertible bonds or bonds with warrants on transferable securities, bonds and other debt securities, money market instruments, issued primarily by companies (i) having their registered office, or (ii) carrying on a major part of their commercial activity, or (iii) as holding companies owning predominant interests in companies with their registered office in Switzerland. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Eleanor Taylor Jolidon 01/01/2008 | ||
Martin Moeller 01/01/2008 | ||
Inception Date 07/02/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
SIX SPI TR CHF | Morningstar Switzerland TME NR CHF |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for UBAM - Swiss Equity AD CHF | 30/06/2024 |
|
|
Top 5 Holdings | Sector | % |
ABB Ltd | Industrials | 7.76 |
Novartis AG Registered Shares | Healthcare | 7.72 |
Nestle SA | Consumer Defensive | 7.04 |
UBS Group AG | Financial Services | 6.17 |
Roche Holding AG | Healthcare | 6.16 |
Increase Decrease New since last portfolio | ||
UBAM - Swiss Equity AD CHF |